(Q30467734)

21 June 2017

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis (English)

1 reference

21 June 2017

0 references

placebo-controlled trial

1 reference

1 reference

1 reference

Richards RD

1

1 reference

21 June 2017

Valenzuela GA

2

1 reference

21 June 2017

Davenport KG

3

1 reference

21 June 2017

Fisher KL

4

1 reference

21 June 2017

McCallum RW

5

1 reference

21 June 2017

1 May 1993

1 reference

Digestive Diseases and Sciences

21 June 2017

1 reference

21 June 2017

38

1 reference

21 June 2017

5

1 reference

21 June 2017

811-816

1 reference

Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride

21 June 2017

1 reference

12 December 2020

Effects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus. A double-blind controlled trial

1 reference

12 December 2020

Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology

1 reference

12 December 2020

Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

1 reference

12 December 2020

Definition of a gastric emptying abnormality in patients with anorexia nervosa

1 reference

12 December 2020

Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01295905

1 reference

Dimensions Publication ID

21 June 2017

1000141972

0 references

Fatcat ID

release_qxdlive7znbexl5l46wmmzjyi4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qxdlive7znbexl5l46wmmzjyi4

24 November 2022

mapped directly with Wikidata item

1 reference